These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 28793925)

  • 1. Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins.
    Zanzoni A; Spinelli L; Braham S; Brun C
    Microbiome; 2017 Aug; 5(1):89. PubMed ID: 28793925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing Whole
    Umaña A; Sanders BE; Yoo CC; Casasanta MA; Udayasuryan B; Verbridge SS; Slade DJ
    J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31501282
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.
    Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF
    J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum: an emerging gut pathogen?
    Allen-Vercoe E; Strauss J; Chadee K
    Gut Microbes; 2011 Sep; 2(5):294-8. PubMed ID: 22067936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
    Kumar A; Thotakura PL; Tiwary BK; Krishna R
    BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.
    Strauss J; Kaplan GG; Beck PL; Rioux K; Panaccione R; Devinney R; Lynch T; Allen-Vercoe E
    Inflamm Bowel Dis; 2011 Sep; 17(9):1971-8. PubMed ID: 21830275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
    Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
    Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusobacterium nucleatum: a commensal-turned pathogen.
    Han YW
    Curr Opin Microbiol; 2015 Feb; 23():141-7. PubMed ID: 25576662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Manipulation and Virulence Assessment of Fusobacterium nucleatum.
    Peluso EA; Scheible M; Ton-That H; Wu C
    Curr Protoc Microbiol; 2020 Jun; 57(1):e104. PubMed ID: 32539234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both?
    Slade DJ
    Trends Cancer; 2021 Mar; 7(3):185-187. PubMed ID: 33309240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of
    Cochrane K; Robinson AV; Holt RA; Allen-Vercoe E
    Microb Genom; 2020 Feb; 6(2):. PubMed ID: 31661053
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.
    Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA
    mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological Pathways Triggered by
    de Andrade KQ; Almeida-da-Silva CLC; Coutinho-Silva R
    Mediators Inflamm; 2019; 2019():7241312. PubMed ID: 31341421
    [No Abstract]   [Full Text] [Related]  

  • 16. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine may promote the progression of
    Du X; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Hu Q; Tian Q; Liang L; Zhao X; Li J; Zhao M; Fu X
    Virulence; 2024 Dec; 15(1):2350904. PubMed ID: 38725098
    [No Abstract]   [Full Text] [Related]  

  • 18. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection.
    Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X
    Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of coaggregation between Porphyromonas gingivalis and Fusobacterium nucleatum on the host response to mixed infection.
    Polak D; Shapira L; Weiss EI; Houri-Haddad Y
    J Clin Periodontol; 2012 Jul; 39(7):617-25. PubMed ID: 22607053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication Study:
    Repass J;
    Elife; 2018 Mar; 7():. PubMed ID: 29533182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.